Cancer scientist Dr. Dan Theodorescu has been named to lead the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, the hospital announced May 24.
Theodorescu, who now serves as director of the University of Colorado Comprehensive Cancer Center, starts July 1.
He replaces Dr. Steven Piantadosi, who stepped down in August to head a Cedars-Sinai research center before announcing a pending move to Harvard Medical School. The cancer institute has since been run by Interim Director Dr. Howard M. Sandler.
Theodorescu, a native of Romania who grew up in Canada, is considered a nationally recognized cancer researcher who has made major cancer therapeutic discoveries.
During his eight years at the University of Colorado, the professor of surgery and pharmacology oversaw the only National Cancer Institute-designated cancer center in the state.
In the lab, he is known for work on molecular mechanisms underlying bladder cancer and turning them into medical treatments.
He has published more than 300 journal articles and is founding co-editor of Bladder Cancer, the first journal of its kind.
At Cedars-Sinai, Theodorescu will manage a complex and growing integrated cancer program, according to the hospital. He brings a vision for cancer care that employs precision medicine, “big data,” and population health research.
Health business reporter Dana Bartholomew can be reached at firstname.lastname@example.org. Follow him on Twitter @_DanaBart.
You May Also Like
- Cedars-Sinai Researchers Develop Drug to Combat Pancreatic Cancer
- Developers Expand Medical Complex Near DTLA
- TOP DOCTORS LOS ANGELES: ONCOLOGY
- Cedars-Sinai Awarded $2.6M to Study Depression in Heart Failure Patients
- Cedars-Sinai Launches Program to Speed Up Treatments of Gut-Related Illnesses
- Cedars-Sinai Appoints New COO
- Cedars-Sinai Awarded $12 Million to Study Deadly Lung Diseases
- Cedars-Sinai Joins Forces With Synthetic Biologics to Develop IBS Drug